Lishomwa Ndhlovu - Google Scholar
Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated … LC Ndhlovu, T Umaki,...
Ndhlovu, Lishomwa (Lish) - Cornell University
Lishomwa (Lish) Ndhlovu Professor of Immunology in Medicine. Affiliation; Publications; Research; Background; Contact; External Relationships
Lishomwa (Lish) Ndhlovu | Weill Cornell Medicine
Lishomwa (Lish) Ndhlovu Title Professor of Immunology in Medicine CWID lndhlovu Department Phone (T) 212 746 4007 Profiles VIVO
Lishomwa Ndhlovu | Graduate School of Medical Sciences
Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists. © …
Dr. Lishomwa “Lish” Ndhlovu Takes the Lead - amfAR, The …
2022年11月11日 · Lishomwa “Lish” Ndhlovu, M.D., Ph.D., is a proponent and practitioner of translational medical research—a multi-step process that expedites the transformation of basic science and understanding about illness into health interventions. He also understands that translational research withers in isolation.
Dr. Lishomwa Ndhlovu | Newsroom
Researchers at Weill Cornell Medicine and the epigenetics company TruDiagnostic have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age.
Lishomwa C. Ndhlovu's research works | Weill Cornell Medical …
Lishomwa C. Ndhlovu's 16 research works with 96 citations and 1,050 reads, including: The latent HIV reservoir: current advances in genetic sequencing approaches
Lishomwa (Lish) Ndhlovu, M.D., Ph.D. | Science | AAAS
Dr. Ndhlovu is a professor of immunology at Weill Cornell Medicine in New York and principal investigator of the HIV and Emerging Pathogens Immunopathogenesis Laboratory in the Division of Infectious Diseases, also at Weill Cornell.
Lishomwa Ndhlovu, MD, PhD | UCSF-Bay Area Center for AIDS …
Research Scientist, University of Hawaii. This project that seeks to facilitate the elimination of HIV/SIV infected cells through a concerted study of a novel immune regulatory pathway that when blocked restores T cell function capable of depleting latently HIV/SIV infected T cells and thus serve as a novel HIV eradication approach.
New Chair Appointed to amfAR’s Scientific Advisory Committee
2022年6月14日 · Lishomwa “Lish” Ndhlovu, M.D., Ph.D., has been appointed to a three-year term as chair of amfAR’s Scientific Advisory Committee, a volunteer group of leading researchers that reviews grant applications submitted to amfAR.